AMLX
Amylyx Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Amylyx Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Largest filed tie
0
filed ties
Fund move
Fund move
+10.71%
vs ±25.6% implied · ×0.42
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $300.4M | 14.45% | +0.59% | |
| 2 | BlackRockBlackRockindex-like | $158.5M | 7.63% | −0.02% | |
| 3 | Perceptive AdvisorsPerceptive | $149.7M | 7.20% | +0.60% | |
| 4 | TCG Crossover ManagementTCG Crossover | $112.1M | 5.39% | 0.00% | |
| 5 | Commodore CapitalCommodore Capital | $101.5M | 4.88% | 0.00% | |
| 6 | Jupiter TopcoJupiter Topco | $94.0M | 4.52% | — | |
| 7 | Saturn V Capital ManagementSaturn V | $83.0M | 3.99% | +6.30% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $75.9M | 3.65% | +2.00% | |
| 9 | Morgan StanleyMorgan Stanley | $56.2M | 2.70% | +43.91% | |
| 10 | Driehaus Capital ManagementDriehaus | $54.5M | 2.62% | +1.67% | |
| 11 | First Light Asset ManagementFirst Light | $54.3M | 2.61% | −5.25% | |
| 12 | Franklin ResourcesFranklin Resources | $53.0M | 2.55% | +30.45% | |
| 13 | Goldman Sachs GroupGoldman Sachs | $51.3M | 2.47% | +8.84% | |
| 14 | State StreetState Streetindex-like | $46.8M | 2.25% | +10.16% | |
| 15 | Geode Capital ManagementGeodeindex-like | $41.9M | 2.02% | +5.63% | |
| 16 | JPMorgan ChaseJPMorgan Chase | $34.9M | 1.68% | +1067.24% | |
| 17 | Adage Capital Partners GPAdage Capital Partners GP | $34.1M | 1.64% | −46.64% | |
| 18 | SirenSiren | $26.6M | 1.28% | +20.37% | |
| 19 | 683 Capital Management683 Capital Management | $24.7M | 1.19% | −15.40% | |
| 20 | Eventide Asset ManagementEventide | $23.8M | 1.15% | −12.31% | |
| 21 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $19.1M | 0.92% | +12.36% | |
| 22 | Alyeska Investment GroupAlyeska Investment | $18.9M | 0.91% | new | |
| 23 | Almitas CapitalAlmitas Capital | $17.5M | 0.84% | −54.07% | |
| 24 | Dimensional Fund AdvisorsDimensional | $16.2M | 0.78% | −0.08% | |
| 25 | Jones Hill CapitalJones Hill Capital | $16.1M | 0.77% | −44.08% |
207 managers report $2.1B of Amylyx Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; FMR is largest at 14.45%.
Amylyx Pharmaceuticals, Inc.
28.86
+0.18 · +0.63%
post 29.02 +0.55%
Expected move
Inputs8Q avg ±5.7%·×1.79·rich
straddle ±10.5%
spot 28.86exp Nov 20ATM strike 29ATM straddle 3.55IV 64%